Health ❯Healthcare ❯Obesity ❯Treatment Options

Novo Nordisk

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients